The 2024 report, Brain Health – Time Matters, builds upon the foundational work of the 2015 MS Brain Health initiative, now broadening its focus to address critical care for neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
Co-authored by a team of experts, including Professor Gavin Giovannoni, Professor Helmut Butzkueven, and Dr. Mitzi Williams, this report delivers updated strategies designed to support timely diagnosis, effective treatment, and proactive monitoring.
Emphasizing the need for early and accurate diagnosis, this section outlines how rapid identification can significantly impact patient outcomes. It explores the latest tools and techniques available to improve diagnostic accuracy, particularly for MS, NMOSD, and MOGAD, ensuring that patients receive the right care as quickly as possible.
This section advocates for tailored treatment plans that consider each patient’s unique needs, from pharmacological therapies to lifestyle adjustments. It underscores the importance of flexible treatment plans that can adapt as a patient’s condition evolves, enhancing quality of life and reducing disease progression.
Highlighting the importance of continuous monitoring, this section details methods for tracking disease activity and treatment efficacy. Regular assessments allow clinicians to make informed adjustments, ensuring that patients remain on the most effective treatment paths.
The report concludes with a discussion on the broader impacts of MS, NMOSD, and MOGAD, focusing on socio-economic challenges and the need for supportive policies. It encourages healthcare providers and policymakers to work together to reduce barriers to care, improve patient outcomes, and advocate for funding and resources that address the long-term needs of patients and their families.
By exploring these four essential areas, Brain Health – Time Matters 2024 offers a practical guide for healthcare professionals, caregivers, and policymakers aiming to improve outcomes for patients with neuroimmune diseases.
To learn more, download the full report below and explore how timely, individualized care can truly make a difference.
Professor Helmut Butzkueven, Professor Gavin Giovannoni, Sofia Arkelsten, Professor Giancarlo Comi, Kathleen Costello, Michael Devlin, Professor Dr. Jelena Drulovic, Dr. Emma Gray, Jodi Haartsen, Dr. Anne Helme, Jana Hlaváčová, Elisabeth Kasilingam, Professor Yaou Liu, Dr. Thomas Mathew, Dr. Saúl Reyes, Professor Jérôme de Sèze and Dr. Mitzi J. Williams.
